Advertisement

Topics

Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy

08:05 EDT 23 May 2011 |

Bluebird Bio is one of those fortunate companies that can say the top peer-reviewed journals in biomedical research—Science and Nature—have run articles featuring its two lead drug candidates while they are still at the earliest phase of development. CEO Nick Leschly doesn’t want to sound ungrateful—the buzz doesn’t hurt—but he seems like he’s had enough [...]

Original Article: Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy

NEXT ARTICLE

More From BioPortfolio on "Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...